Strategic Health Care is highly effective when it comes to achieving results, a hallmark that our clients have come to expect. Our team of professionals is skilled at understanding our clients’ businesses, devising strategies that generate the results that meet – and exceed – our clients’ specific objectives, and presenting our clients’ strongest position to legislators and policymakers.

We have represented our clients with respect to virtually all major health care legislation enacted by Congress and implemented by federal agencies throughout more than a decade, including budget and appropriations matters; new payment systems for hospitals, ambulatory providers, and physicians; CMS pilots & demos; managed care; health care reform; health care information privacy (HIPAA); physician self-referral; maintenance of tax-exemption status for nonprofits; programs and funding for NIH and other federal research agencies; and drug and medical devices reform.

Examples of the work of the Strategic Health Care team:


  • $45 million USDA grant/loan combo for a hospital in Kentucky for a major construction project.
  • $2.25 million grant for an Ohio facility for participation in a DOD Clinical Study Site for the treatment of post-traumatic stress disorder and traumatic brain injury
  • $2.2 million grant for a Louisiana facility from HRSA for strengthening the safety net for underinsured and uninsured citizens.
  • $1.48 million grant for a California medical facility from HRSA (Health Resources and Services Administration) to be part of a national study on Electronic Medical Records’ impact on care for HIV/AIDS patients.
  • Assisted a national medical specialty organization in securing authorization and funding for an NIH-chartered National Commission on Digestive Diseases to develop a long-range research, prevention, and education plan.


  • Secured more than $3 billion over five years for a coalition of hospitals for advantageous changes to their Medicare area wage index classifications.
  • Secured passage of legislation and issuance of regulations to provide additional Medicare reimbursement for a new implantable device on behalf of ophthalmology organizations, eye-care product manufacturers, and ambulatory surgery associations.
  • Obtained “pass-throughs” and other supplemental reimbursement under the new hospital outpatient prospective payment program for several medical device manufacturers.


  • Achieved numerous favorable rulings on behalf of major ambulatory surgery centers (ASC) trade associations, e.g., establishing a Medicare ASC benefit, expanding the procedures reimbursed in an ASC, preserving physician ownership of ASCs under the Stark and anti-kickback laws, and mandating the development of a new Medicare payment system for ASCs.
  • Prevented loss of several millions of dollars for teaching hospital by persuading CMS to modify interpretation of graduate medical education regulations.
  • Worked to effectively eliminate CMS’ use of LCAs, a draconian coverage policy that was heretofore freely used by CMS to limit utilization of “high-priced” drugs.
  • Built and implemented a plan that convinced CMS to remove a “fail-first” provision for a specific class of drugs.

Congressional Appropriations (Not Presently Available) 

  • $1.3 million for a hospital in Tennessee for a Family Medicine Clinic
  • $1.2 million for an Arkansas medical center for a cancer center.
  • $850,000 for a California hospital’s renovation project.
  • $800,000 for a hospital in New York for Health Information Technology.
  • $675,000 for a hospital in Minnesota for an Emergency Department Expansion project.
  • $600,000 for a hospital in Arkansas to update its Radiology Department with new MRI and CT equipment.
  • $300,000 for a hospital in New York for an Emergency Department Expansion.